Quality of Life of Taiwan People Living With HIV
Investigation on Quality of Life and Related Factors of Taiwan People Living With HIV
1 other identifier
observational
550
1 country
1
Brief Summary
To survey QoL and relevant factors in PLWH
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 20, 2019
CompletedFirst Submitted
Initial submission to the registry
August 15, 2019
CompletedFirst Posted
Study publicly available on registry
August 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 20, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2020
CompletedAugust 21, 2019
August 1, 2019
4 months
August 15, 2019
August 17, 2019
Conditions
Outcome Measures
Primary Outcomes (3)
QoL status of Patient Living with HIV (PLWH) by WHOQOL-HIV Brief questionaire
in 4 weeks
Medical Outcome of Patient Living with HIV (PLWH) by MOS-HIV questionaire
in 4 weeks
Stigma Scale of Patient Living with HIV (PLWH) by Berger's HIV Stigma Scale
an average of 1 year
Interventions
this is an observational survey and no intervention is given
Eligibility Criteria
adult HIV-1 infected patients
You may qualify if:
- adult patient living with HIV, aged \>= 18 years old
You may not qualify if:
- known cognitive dysfunction or attention deficient to complete the survey
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Taiwan AIDS Nurse Societylead
- GlaxoSmithKlinecollaborator
Study Sites (1)
National Taiwan University Hospital
Taipei, 110, Taiwan
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research & Development Board Director
Study Record Dates
First Submitted
August 15, 2019
First Posted
August 21, 2019
Study Start
June 20, 2019
Primary Completion
October 20, 2019
Study Completion
December 20, 2020
Last Updated
August 21, 2019
Record last verified: 2019-08